The approval was based on a randomized, double-blind, placebo-controlled phase 3 trial, which included 447 postmenopausal women with acquired, generalized HSDD.

Don't lead your cousins astray over the holidays by taking them to an overhyped, overpriced and overcrowded pop-up bar. We ...

Topline phase 3 results show retatrutide led to meaningful weight reduction and pain relief in adults with overweight or obesity and knee OA.

This article is a continuation of the 1st Stryker Brigade Combat Team (SBCT), 4th Infantry Division’s “Moneyball for Gunnery” ...

Customer experience shapes brand perception and loyalty, but gaps prevent many organizations from optimizing performance ...

Using longitudinal data from the US Health and Retirement Study, this study applied causal inference modeling to disentangle ...

Long COVID still affects people worldwide with stubborn symptoms like fatigue and cognitive issues. A clinical trial tested ...

A new study published in the International Journal of Geriatric Psychiatry suggests that difficult experiences in childhood ...

The maker of Zepbound reported results from a study of retatrutide, which targets three hormones in the body and led to much more weight loss than any approved drug.

Impaired kidney function is associated with increased circulating levels of most Alzheimer disease blood biomarkers.

Amazon’s Echo Show 21 (their biggest Echo Show yet) rarely goes on sale, but this $50 discount makes the Echo series’ ...

Real and sham acupuncture were more effective at improving breast cancer survivors' perceived cognitive impairment compared ...